María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
Essen University Hospital
Essen, AlemaniaPublications in collaboration with researchers from Essen University Hospital (2)
2022
-
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
Nature Medicine, Vol. 28, Núm. 8, pp. 1640-1645
2016
-
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial
Annals of Oncology, Vol. 27, Núm. 3, pp. 417-423